Cancer Firm Lands One of Europe’s Biggest Biotech Funding Rounds

(Bloomberg) -- The German cancer-treatment researcher BioNTech AG raised $325 million from investors, one of the largest financing rounds ever by a European biotechnology company.

Bloomberg Quint

Add BloombergQuint App to Home screen.